We sought to evaluate whether residence at high altitude is associated with the development of obesity among those at increased risk of becoming obese. Obesity, a leading global health priority, is often refractory to care. A potentially novel intervention is hypoxia, which has demonstrated positive long-term metabolic effects in rats. Whether or not high altitude residence confers benefit in humans, however, remains unknown. Using a quasi-experimental, retrospective study design, we observed all outpatient medical encounters for overweight active component enlisted service members in the U.S. Army or Air Force from January 2006 to December 2012 who were stationed in the United States. We compared high altitude (>1.96 kilometers above sea level) duty assignment with low altitude (<0.98 kilometers). The outcome of interest was obesity related ICD-9 codes (278.00-01, V85.3x-V85.54) by Cox regression. We found service members had a lower hazard ratio (HR) of incident obesity diagnosis if stationed at high altitude as compared to low altitude (HR 0.59, 95% confidence interval [CI] 0.54–0.65; p<0.001). Using geographic distribution of obesity prevalence among civilians throughout the U.S. as a covariate (as measured by the Centers for Disease Control and Prevention and the REGARDS study) also predicted obesity onset among service members. In conclusion, high altitude residence predicts lower rates of new obesity diagnoses among overweight service members in the U.S. Army and Air Force. Future studies should assign exposure using randomization, clarify the mechanism(s) of this relationship, and assess the net balance of harms and benefits of high altitude on obesity prevention.
Citation: Voss JD, Allison DB, Webber BJ, Otto JL, Clark LL (2014) Lower Obesity Rate during Residence at High Altitude among a Military Population with Frequent Migration: A Quasi Experimental Model for Investigating Spatial Causation. PLoS ONE 9(4): e93493. doi:10.1371/journal.pone.0093493
Editor: Olga Y. Gorlova, Geisel School of Medicine at Dartmouth College, United States of America
Received: December 18, 2013; Accepted: March 5, 2014; Published: April 16, 2014
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: The authors’ fees were paid by Armed Forces Health Surveillance Center. Those affiliated with the funding organization contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.
Competing interests: JDV intends to participate in development, evaluation, and/or patenting of device(s) related to altitude simulation for the US government within the next five years. This disclosure does not alter the authors’ adherence with PLoS policies on data sharing and the other authors declare they have no competing interests.
Obesity is a global health priority with medical, societal, financial, and security ramifications. ,  It threatens the operational capacity of the U.S. military, both by its increasing prevalence among the present force  and its impact on the qualified applicant pool .
The burden of disease remains high despite implementation of several lifestyle-based public health interventions. Within the U.S. armed forces, despite universal access to free healthcare, high prevalence of physical activity  and regulations requiring a healthy body weight (Department of Defense Directive 1308.1),  excess weight diagnoses have increased markedly.  This is associated with decreased length of service ,  and costs exceeding $1 billion annually.  Ultimately, more effective interventions are needed–both for this population and for individuals around the globe.
Hypoxia has been investigated as a hypophagic agent in rats since the 1960s – and has recently gained attention as a potential therapeutic agent in humans. ,  Human interventional trials have demonstrated reduced appetite and body fat in hypoxic conditions, including high altitude travel, – although such trials have been of short duration. Recently, we documented an inverse, dose-response association between the altitude of one’s residence and obesity prevalence in the United States. – As compared to their counterparts residing in high altitude counties, individuals in low altitude counties had over 4 times the prevalence of obesity, after adjusting for diet, physical activity, smoking, demographic and other factors. Although this finding suggests a potential long-term metabolic benefit from hypoxia, the dataset lacked duration of residence and temporal sequence of exposure and outcome, and was thus limited by the potential of reverse causation. Other studies in Nepal, India, and Argentina have shown similar results –.
This present study analyzes whether long-term residence at high altitude alters progression from overweight to obesity. As a large, relatively homogenous population with expansive and available demographic, occupational, geographic, and health records, the military population provides an unparalleled cohort for investigating this question. In addition, their migratory pattern derives from external orders (i.e., semi-random exposure assignment) rather than individual prerogative, representing a form of quasi-experiment .
Materials and Methods
This dataset was originally constructed for public health surveillance as approved by Reports and Request Review at the Armed Forces Health Surveillance Center. Analysis of the deidentified dataset for generalizable knowledge was exempted as non-human subjects research by the Air Force Research Lab Institutional Review Board at Wright-Patterson Air Force Base, OH.
This quasi-experimental, retrospective study with a surveillance period of 1 January 2006 to 31 December 2012 included enlisted service members in the active component of the U.S. Army or Air Force with at least 2 years in service, an overweight (but not obese) enlistment body mass index (BMI≥25 & <30) and no prior diagnosis of obesity between the time of military enlistment to study entry. We were interested in evaluating an overweight population who would be at risk of progression to obesity during a single duty assignment.
Once a military member met all inclusion criteria, the time they were observed was divided into “segments” of time representing the length of inclusion at a unique duty location assignment. The altitude of each military duty station was defined by the average altitude of the station’s 3-digit unit zip code from WorldClim shuttle radar topography maps  and derived with Geospatial Information System software (ArcGIS version 10.0).  Service members’ unit zip codes were obtained from demographic records in the Defense Medical Surveillance System (DMSS).  There were 28 observations from segments at a 3 digit zip code for which there was not an available altitude; these were included as a missing category. The other altitude categories were selected after data collection to create three equidistant intervals of 0.98 km, taking advantage of the natural break at 1.96 km (see Figure 1).
Figure 1. Histogram of Observed Density by Altitude.
Lines represent altitude categorization based on natural break at 1.96doi:10.1371/journal.pone.0093493.g001
Additional demographic information was collected including age, self-reported race/ethnicity, sex, branch of military service, time in military service, occupation category, baseline BMI, and home of record (this refers to any location specified by the service member–which may indicate location of residence upon military entry or intended location of residence after completion of military service). Furthermore, to account for income disparities among military members based on duty location, the 2009 basic allowance for housing (BAH) averaged over each 3-digit zip (for the unmarried, lowest ranking pay-grade) was utilized as an additional covariate, based on publically available data.  A total of 85,098 segments (periods at a unique duty location) were excluded because the 3-digit zip reflected an Army (or Fleet) Post Office that was not located in a U.S. State (such as Europe or Guam) (n = 61,677), or was invalid (n = 23,421). One individual was excluded due to missing baseline BMI. If a model includes civilian obesity prevalence from NHANES, the New England census region is excluded due to insufficient observations from New England in this dataset .
The outcome of interest was incident clinical obesity, defined by at least one outpatient or inpatient medical encounter coded with the indicator International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code of 278.00 or 278.01 (obesity) or V-code of V85.3x, V85.4, or V85.54 (BMI≥30) in any diagnostic position. A service member could be counted as an incident case only once.
All observations meeting inclusion criteria were analyzed using Cox regression with “time 0” defined as the time when an individual entered the study. Time 0 began in the middle of the surveillance period for service members who reached 2 years of active service during the period. For those with gaps in their personnel record lasting greater than 6 months, person-time was restarted at time 0 at the same location after the gap ended. Censoring occurred when a service member separated from military service or changed duty locations, or at the conclusion of the surveillance period. Service members with a change in duty location during the surveillance period contributed person-time at each location. To account for lack of independence when the same individual was observed at different duty stations, a variance estimator was used to cluster observations from the same individual (option “vce” clustering on the individual using Cox regression in Stata version 12).  Personnel records in DMSS only document “permanent” duty assignment and do not account for time spent away from that location (e.g., while on military leave, overseas deployments, and temporary duty assignments). Data analysis was performed using Stata v.11.0–12.1.
Geographic determinants other than altitude (e.g., rainfall, temperature, sunlight, obese social contacts, and cultural values) could vary between regions or states. Assuming no migration and steady state population weight (at the spatial resolution assessed), the cumulative (relative) effect of all of these geographic exposures should be revealed by the resultant obesity prevalence among civilians in these areas. The assumptions create limitations, and the spatial variation at this spatial resolution could be partially determined by altitude variation. Nonetheless, obesity prevalence provides a surrogate for other, unmeasurable geographic factors. Thus, civilian obesity rates were obtained from the Centers for Disease Control and Prevention’s (CDC) BRFSS for self-reported height and weight at the state level  and from the NHANES and REGARDS databases for measured height and weight based on the regional level as reported elsewhere.  These percentages were manually assigned to each zip code range based on publically available 3-digit zip codes for each state , .
Using obesity prevalence as a surrogate for unmeasured spatial determinants doesn’t account for time-dependent spatial features (i.e., features that exert a different effect based on length of residence). For example, smoking behavior varies spatially throughout the United States,  is socially transmitted,  and is associated with significantly more weight gain for recent than long-term quitters.  Because individual level smoking behaviors were not available, adjustments for state-level self-reported current smoking status (obtained from the 2011 BRFSS dataset) were used in robustness analyses .
To account for non-random aspects of the assignment process, such as personnel requests, which may influence the process differently by occupation, robustness analysis was performed. The seven occupational categories were stratified into separate analyses to assess the magnitude of the association across occupational substrata.
Summary demographics by exposure category are provided in Table 1. There were 98,009 individuals who contributed a median 3.2 years of exposure. The median length of each segment, reflecting unique duty locations, was 1.2 years of qualifying observation (time after diagnosis and time while members had less than two years of service not included).
Table 1. Demographic and Military Characteristics among Overweight Active Component Army and Air Force Service Members by Altitude, 2006–2012.doi:10.1371/journal.pone.0093493.t001
There was a small but sizable portion of the population stationed at high altitude with 16,111 person-years observed. Demographic characteristics were generally similar by altitude category with black race and healthcare occupations being somewhat more common at low altitude than at high altitude. Military enlistment body mass indices (BMIs) were similar across strata of altitudes with high altitude having a slightly greater mean BMI. Covariates listed in Table 1 were included in the final model to correct for minor demographic differences.
Service members stationed at high altitude had a 41% (95% confidence interval [CI] 35%–46%; p<0.001) lower hazard rate of obesity as compared to those stationed at low altitude, after controlling for enlistment BMI, branch of service, time in service, occupation, sex, race/ethnicity, age, and housing allowance (Table 2 and Figure 2). Unadjusted results were similar (41%; 95% CI 35%–47%; p<0.001). Relative to those in the healthcare career field, those in aircrew occupations had a 46% (95% CI 34%–56%) lower hazard rate of an obesity diagnosis.
Figure 2. Cumulative Hazard Function.
Cumulative Hazard of Obesity Diagnosis based on Cox Proportional Hazards Model Adjusted for Enlistment BMI, Sex, Race, Occupation, Time in Service, Branch of Service, Housing Allowance, and Age. The Red Curve is High Altitude and the Blue Curve is Low Altitude.doi:10.1371/journal.pone.0093493.g002
Table 2. Hazard Ratios by Fully Adjusted Cox Model.doi:10.1371/journal.pone.0093493.t002
Several analyses were performed to investigate the robustness of the findings. Model diagnostics demonstrated consistency of proportional hazard throughout the seven-year period (Figure 3). Those identifying Colorado as their “home of record” could have increased reason to request Colorado duty assignment. Controlling for Colorado “home of record,” however, altered the hazard ratio (HR) of high altitude only slightly from 0.59 to 0.60. Manually assigning altitude categories to the 28 observations with missing altitude did not alter the results (HR 0.59, 95% CI 0.54–0.65).
Figure 3. Log-Log Plot for Goodness of Fit with Proportional Hazards Assumption.
The x-axis represents the natural log of analysis time in days.doi:10.1371/journal.pone.0093493.g003
When dividing altitude into three equal intervals of 0.78 km based on the range of available altitudes (0–2.34 km) independent of natural breaks, those stationed at high altitude (>1.56 km) had lower hazard of obesity (HR 0.77; 95% CI 0.72–0.83) than those at low altitude in the fully adjusted model, but some individual duty locations above 1.56 km did not have a protective association. Alternatively, substituting altitude as a continuous variable, there was a 6% lower hazard of obesity (HR 0.94; 95% CI 0.91–0.96) per kilometer gained above sea level.
When included as a covariate, civilian obesity prevalence (as defined by Behavioral Risk Factor Surveillance System [BRFSS], National Health and Nutrition Examination Survey [NHANES], and Reasons for Geographic and Racial Differences in Stroke [REGARDS] datasets) was strongly related to military obesity incidence. After incorporating prevalence from all three civilian datasets in the fully adjusted model, high altitude duty assignment remained a protective association (HR 0.83; 95% CI 0.73–0.95) as compared to low altitude. This model predicted a 10% increase (HR 1.10; 95% CI 1.09–1.11) in obesity incidence among service members for every 1% increase in regional obesity prevalence as determined by REGARDS. The relationship between civilian obesity prevalence and hazard of obesity diagnosis remained consistent even when limiting the dataset to those stationed at low altitude (i.e., the unexposed) (HR 1.11; 95% CI 1.10–1.12). Further, all three independent data sources demonstrated an increased hazard of obesity diagnosis in areas with increased obesity prevalence (Table 3). Adjustment based only on actual measurements of height and weight (i.e., using NHANES or REGARDS) resulted in high altitude duty assignment having a non-significant protective association (NHANES: HR 0.94; 95% CI 0.84–1.07; and REGARDS: HR 0.91; 95% CI 0.82–1.02 – Table 3).
Table 3. Hazard of Obesity Incidence Based on Different Measures of Civilian Obesity.doi:10.1371/journal.pone.0093493.t003
Results were similar when stratified by occupation, although aircrew personnel did not necessarily derive additional benefit from high altitude duty assignment (Table 4).
Table 4. Hazard of Obesity Diagnosis at High Altitude vs. Low when stratified by Occupation.doi:10.1371/journal.pone.0093493.t004
When replacing altitude and civilian obesity prevalence with a categorical variable for census region, the regional variation in obesity incidence demonstrated increased hazard in the center of the country in the two census regions immediately west of the Mississippi River (West North Central and West South Central – Table 5).
Table 5. Regional Variation in Obesity Hazard and Relationship with Civilian Obesity.doi:10.1371/journal.pone.0093493.t005
State-level prevalence of self reported current smoking among civilians was inversely associated with an obesity diagnosis among military members. For every 1% increase in smoking prevalence, there was a 4% lower hazard of an obesity diagnosis (HR 0.96, 95% CI 0.95–0.97) in the full model. Adjusting for smoking strengthened the inverse association between altitude and obesity hazard. The HR of obesity at high altitude (>1.96 km) decreased to 0.52 (95% CI 0.47–0.58) as compared to those living <0.98 km. Additionally, there was a dose response pattern with those living between 0.98 km and 1.96 km exhibiting a HR of 0.86 (95% CI 0.82–0.91) for new diagnoses of obesity as compared to those living <0.98 km. Adjusting for smoking prevalence also magnified the relationship between altitude and obesity hazard when modeling altitude as a continuous variable. Prior to adjustment the HR was 0.94 (95% CI 0.91–0.96) and after adjustment it was 0.86 (95% CI 0.83–0.89) per kilometer above sea level.
Among overweight service members in the U.S. Army and Air Force between January 2006 and December 2012, those stationed at higher altitude duty locations had a lower incidence of obesity. This provides the first evidence of a longitudinal association between living at high altitude and long-term obesity protection.
Both behavioral and biological mechanisms could explain this finding. While the association between civilian obesity prevalence and military obesity incidence could reflect shared behavioral mechanisms (e.g., a common built environment), social norming, and social transmission, ,  service members are partially shielded from these mechanisms by having consistent access to healthy foods at military commissaries, a peer group of other military members, and incentives to remain physically active, such as periodic physical fitness tests.
On the contrary, this association could reflect shared biological exposures, such as environmental pollutants, climatic factors, and hypoxia. Although this study cannot entirely discriminate between these exposures, it provides support for the hypoxia hypothesis. First, high altitude duty assignment conferred a significant protective effect even after adjusting for a home of record of Colorado, the state with the lowest obesity prevalence. Second, this association pertained to all occupational strata other than aircrew, who were protected regardless of duty location, reflecting perhaps their intermittent exposure to the hypobaric conditions of aircraft.
The role of hypoxia is also consistent with several hormonal mechanisms proposed by other investigators. Leptin, which helps suppress appetite, is transcribed under the influence of hypoxia inducible factor (HIF) . Some have found serum leptin rises at high altitude,  and the leptin receptor also appears upregulated by hypoxia.  Thus, leptin transcription and signaling alterations could contribute to appetite changes even if serum concentration is unchanged. Likewise, other proposed hormonal mediators such as cholecystokinin (CCK)  and norepinethrine have been shown to increase at altitude, ,  which could influence appetite directly (CCK) or indirectly (norepinephrine) via reduced blood flow to the gut . Erythropoietin (EPO), which prevents obesity in mice through non-erythroid receptors,  is another potential factor. Although the extent to which endogenous EPO fluctuates with altitude is unclear, it is clearly related to hypoxia and dosing requirements of exogenous EPO in kidney failure patients are reduced at high altitude.  EPO phosphylates paroxysome proliferator-activated receptor γ,  which is the so-called “master switch” of adipocyte development .
While this analysis featured chronic exposure to hypobaric pressure among those stationed at high altitude, future studies could explore whether such conditions are necessary to achieve a similar effect. Long-term exposure to normobaric hypoxemia in chronic lung disease is associated with cachexia, which is reversed with ventilatory support,  and short-term pulsatile hypoxia (such as in an altitude tent or pressurized aircraft) has also been proposed as a therapy for obesity. ,  Furthermore, other normobaric alternatives could be investigated. For instance, rodents experimentally administered cyanamide  or carbon monoxide  have lower body weight. Carbon monoxide, which has been proposed as a therapeutic agent for a range of human diseases,  can be delivered in small doses that are nonfatal (such as those provided by secondhand cigarette smoke exposure)  stimulated endogenously through HO-1 inducers, ,  or given by other delivery mechanisms.  In fact, the HO-1 inducers are already known to stimulate weight loss and prevent obesity in rodents. ,  Furthermore, previously documented connections between ferritin, phlebotomy, and insulin resistance ,  have been shown to connect through the (hypoxia related) HIF1α pathway .
When considering hypoxia as a therapeutic agent, the potential risks warrant caution. Obese individuals may be at greater risk for altitude sickness, particularly at an altitude above 3600 meters.  This provides additional support for the use of hypoxia as a preventive–as in our study–rather than as a therapeutic agent. Mental illness constitutes another potential harmful association with hypoxia exposure, as demonstrated recently by the frequency of suicide and cocaine abuse at high altitude. ,  Hypophagia, while therapeutic for obesity, is also a symptom of depression. Therefore, even if the metabolic effects of hypoxia are clearly favorable, the holistic balance of benefits and harms may tilt in either direction based on the individual patient.
This study featured a large, relatively homogenous population with longer follow up than any previous study identified. Although the findings are consistent with earlier interventional trials, –,  its longer duration provides a notable contribution given the limitations of short-term trials. First, since obesity is a chronic disease, short-term benefits are of questionable public health utility unless they are sustainable. Second, humans adapt to high altitude exposure, so any short-term effect could be attributable to the physiologic changes associated with the adaptation process rather than a steady state effect at altitude. Third, some adaptations to high altitude could modify body weight without altering body fat. Hemoconcentration, for example, would reduce total body water and body mass without reducing body fat .
This study’s quasi-experimental design–by which the intervention of duty assignment was neither chosen by the participants nor randomly allocated by the investigators–reduced the likelihood of residual confounding (i.e., the outcome of obesity would more likely reflect the impact of residence itself, rather than the participants’ choice of residence). Additionally, the study design is inherently translational due to the real world conditions which allows assessment of effectiveness more than efficacy.  Finally, outcomes were determined by healthcare providers in the routine course of patient care who had no knowledge of this investigation.
Nonetheless, the study should be interpreted in light of its limitations. Although service members are not free to reside anywhere in the United States, the assignment process is not entirely random. Those with a healthier lifestyle may have been more likely to request assignment at high altitude, although data on such requests are not available. The homogeneity of effect across all career fields, however, suggests the assignment process is not responsible for the association seen. Another limitation is the use of the so-called “permanent” duty location to define exposure. Unplanned cross-over likely occurred during military leave, deployments, and temporary duty, thus biasing our results toward the null. In addition, potential confounding variables (e.g., smoking status) were not measured. Adjustment for civilian smoking prevalence suggested this missing data biased our results to the null. This adjustment also suggested that missing smoking data may have partially explained the lower than expected obesity hazard in the East South Central census region (Table 5).
While this study’s military population presents a unique opportunity to evaluate a large cohort of frequently migrating humans, it could be argued that such findings are not generalizable to the civilian population. Several features of this study, however, favor a broader applicability of its findings beyond the U.S. military. First, it evaluates an association previously documented among civilians  using a quasi-experimental design. Second, the findings suggest that service members in the study mirrored geographically collocated civilians as it relates to obesity outcomes. In fact, incident obesity diagnoses occurred at rates proportionate to the prevalence of obesity in the local civilian population. This finding is not surprising since the military is made up of a socioeconomically diverse source population of civilians who previously resided throughout the United States. Third, although screening and training of applicants results in a healthy working population, this is not dissimilar to the recruitment process of clinical trials featuring healthy subjects. Fourth, military personnel in this study were only included after completing at least two years of service, and thus had moved beyond training settings with mandated dietary choices and physical training programs. Finally, results were consistent across occupational substrata. If the effect of altitude on obesity were contingent on something unique to the military lifestyle, one would expect occupational substrata classically associated with a military ethos (e.g., infantry) to demonstrate a stronger effect size than those in other fields, such as healthcare.
Aside from the translational findings relating to obesity, our study also provides at least two methodological contributions for making causal inferences of spatial determinism. Although the classic components of descriptive epidemiology (i.e., person, place, and time) demonstrate the importance of place in disease pattern recognition, analytic techniques are needed to evaluate if a disease is merely located in a particular place, or if that place actually exerts a causal influence on the development of the disease. Our first contribution to this end is the identification of the U.S. military as an ideal source population for investigating the causal influence of geographic locations on health. In addition to the characteristics we have outlined (i.e., frequent and assigned migration, data availability, and generalizability), this population is also appropriate because military members may benefit from knowledge of the unique health risks and rewards associated with moving to new places. We also demonstrated a novel method of etiologic assessment using external data. We compared disease prevalence among the extant local population with disease incidence among residents who had recently migrated there, thus accounting for unmeasured factors. In this case, by finding an association between civilian obesity prevalence and military obesity incidence even in low altitude areas, we suspect that geographic determinants of obesity likely extend beyond altitude alone. Similarly, we identified and adjusted for one spatial factor (variance in smoking behaviors) that could impact newly arrived residents differently than long term residents.
In summary, high altitude duty assignment of overweight U.S. military service members is associated with lower rate of obesity diagnoses as compared with low altitude duty assignment, even after adjusting for state level obesity prevalence. Census region residence is a newly identified modifiable risk factor for obesity for this population. Furthermore, the study raises many new avenues of research with significant implications for global health.
The opinions expressed are those of the authors, not the Department of Defense, the US Air Force, the School of Aerospace Medicine, The Uniformed Services University, Trainee Health Surveillance, the University of Alabama at Birmingham or any other institution. Mr. Gi-Taik Oh provided valuable technical assistance in compiling this data. The surveillance project was originally conducted while Dr. Voss was a resident in General Preventive Medicine and Public Health at the Uniformed Services University of the Health Sciences rotating with the Armed Forces Health Surveillance Center. Data and materials availability: The original data used for this analysis is archived with the Armed Forces Health Surveillance Center and data availability is subject to their policies and procedures.
Conceived and designed the experiments: JDV LLC DBA JLO. Analyzed the data: JDV LLC DBA JLO BJW. Contributed reagents/materials/analysis tools: JDV LLC. Wrote the paper: JDV BJW DBA JLO LLC.
- 1. (2012) Accelerating Progress in Obesity Prevention: Solving the Weight of the Nation: The National Academies Press.
- 2. Popkin BM (2011) Is the obesity epidemic a national security issue around the globe? Curr Opin Endocrinol Diabetes Obes.
- 3. Smith TJ, Marriott BP, Dotson L, Bathalon GP, Funderburk L, et al. (2012) Overweight and obesity in military personnel: sociodemographic predictors. Obesity (Silver Spring) 20: 1534–1538. doi: 10.1038/oby.2012.25
- 4. Cawley J, Maclean JC (2012) Unfit for service: the implications of rising obesity for US military recruitment. Health Econ 21: 1348–1366. doi: 10.1002/hec.1794
- 5. 2011 Health Related Behaviors Survey of Active Duty Military Personnel. (2013). http://tricare.mil/tma/dhcape/surveys/coresurveys/surveyhealthrelatedbehaviors/downloads/Final%202011%20HRB%20Active%20Duty%20Survey%20Exec%20Summary.pdf.Accessed: 19 Jun 2013.
- 6. Department of Defense Directive Number 1308.1. DoD Physical Fitness and Body Fat Program. http://www.dtic.mil/whs/directives/corres/pdf/130801p.pdf. Accessed: 8 Mar 2014.
- 7. Brenner B, Cheng D, Clark S, Camargo CA Jr (2011) Positive association between altitude and suicide in 2584 U.S. counties. High Alt Med Biol 12: 31–35. doi: 10.1089/ham.2010.1058
- 8. Packnett ER, Niebuhr DW, Bedno SA, Cowan DN (2011) Body mass index, medical qualification status, and discharge during the first year of US Army service. Am J Clin Nutr 93: 608–614. doi: 10.3945/ajcn.110.007070
- 9. Duration of service after overweight-related diagnoses, active component, U.S. Armed Forces, 1998–2010. MSMR 18: 2–6.
- 10. Dall TM, Zhang Y, Chen YJ, Wagner RC, Hogan PF, et al. (2007) Cost associated with being overweight and with obesity, high alcohol consumption, and tobacco use within the military health system’s TRICARE prime-enrolled population. Am J Health Promot 22: 120–139. doi: 10.4278/0890-1171-22.2.120
- 11. Schnakenberg DD, Krabill LF, Weiser PC (1971) The anorexic effect of high altitude on weight gain, nitrogen retention and body composition of rats. J Nutr 101: 787–796.
- 12. Quintero P, Milagro FI, Campion J, Martinez JA (2010) Impact of oxygen availability on body weight management. Med Hypotheses 74: 901–907. doi: 10.1016/j.mehy.2009.10.022
- 13. Leal TL, Alippi RM, Vargas M, Leon-Velarde F, Bozzini CE (1995) Body weight loss during acute hypoxia: effects of increased convective oxygen transport or previous acclimation. Acta Physiol Pharmacol Ther Latinoam 45: 9–14.
- 14. Elia R, Elgoyhen AB, Bugallo G, Rio ME, Bozzini CE (1985) Effect of acute exposure to reduced atmospheric pressures on body weight, food intake and body composition of growing rats. Acta Physiol Pharmacol Latinoam 35: 311–318.
- 15. Bozzini CE, Lezon CE, Norese MF, Conti MI, Martinez MP, et al. (2005) Evidence from catch-up growth and hoarding behavior of rats that exposure to hypobaric air lowers the body-mass set point. Growth Dev Aging 69: 81–88.
- 16. Norese MF, Lezon CE, Alippi RM, Martinez MP, Conti MI, et al. (2002) Failure of polycythemia-induced increase in arterial oxygen content to suppress the anorexic effect of simulated high altitude in the adult rat. High Alt Med Biol 3: 49–57. doi: 10.1089/152702902753639540
- 17. Kayser B, Verges S (2013) Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies. Obesity Reviews.
- 18. Palmer BF, Clegg DJ (2013) Ascent to altitude as a weight loss method: The good and bad of hypoxia inducible factor activation. Obesity (Silver Spring).
- 19. Surks MI, Chinn KS, Matoush LR (1966) Alterations in body composition in man after acute exposure to high altitude. J Appl Physiol 21: 1741–1746.
- 20. Ge RL, Wood H, Yang HH, Liu YN, Wang XJ, et al. (2010) The body weight loss during acute exposure to high-altitude hypoxia in sea level residents. Sheng Li Xue Bao 62: 541–546.
- 21. Wagner PD (2010) Operation Everest II. High Alt Med Biol 11: 111–119. doi: 10.1089/ham.2009.1084
- 22. Aeberli I, Erb A, Spliethoff K, Meier D, Gotze O, et al. (2012) Disturbed eating at high altitude: influence of food preferences, acute mountain sickness and satiation hormones. Eur J Nutr.
- 23. Netzer NC, Chytra R, Kupper T (2008) Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia. Sleep Breath 12: 129–134. doi: 10.1007/s11325-007-0149-3
- 24. Tschop M, Strasburger CJ, Hartmann G, Biollaz J, Bartsch P (1998) Raised leptin concentrations at high altitude associated with loss of appetite. Lancet 352: 1119–1120. doi: 10.1016/s0140-6736(05)79760-9
- 25. Shukla V, Singh SN, Vats P, Singh VK, Singh SB, et al. (2005) Ghrelin and leptin levels of sojourners and acclimatized lowlanders at high altitude. Nutr Neurosci 8: 161–165. doi: 10.1080/10284150500132823
- 26. Lippl FJ, Neubauer S, Schipfer S, Lichter N, Tufman A, et al. (2010) Hypobaric hypoxia causes body weight reduction in obese subjects. Obesity (Silver Spring) 18: 675–681. doi: 10.1038/oby.2009.509
- 27. Chia M, Liao C-A, Huang C-Y, Lee W-C, Hou C-W, et al. (2013) Reducing Body Fat with Altitude Hypoxia Training in Swimmers: Role of Blood Perfusion to Skeletal Muscles. The Chinese journal of physiology: 2–9.
- 28. Bailey DM, Davies B, Milledge JS, Richards M, Williams SR, et al. (2000) Elevated plasma cholecystokinin at high altitude: metabolic implications for the anorexia of acute mountain sickness. High Alt Med Biol 1: 9–23. doi: 10.1089/152702900320649
- 29. Wasse LK, Sunderland C, King JA, Batterham RL, Stensel DJ (2012) Influence of rest and exercise at a simulated altitude of 4,000 m on appetite, energy intake, and plasma concentrations of acylated ghrelin and peptide YY. J Appl Physiol 112: 552–559. doi: 10.1152/japplphysiol.00090.2011
- 30. Kong Z, Zang Y, Hu Y (2013) Normobaric hypoxia training causes more weight loss than normoxia training after a 4-week residential camp for obese young adults. Sleep Breath.
- 31. Westerterp-Plantenga MS, Westerterp KR, Rubbens M, Verwegen CR, Richelet JP, et al. (1999) Appetite at “high altitude” [Operation Everest III (Comex-‘97)]: a simulated ascent of Mount Everest. J Appl Physiol 87: 391–399.
- 32. Voss JD, Masuoka P, Webber BJ, Scher AI, Atkinson RL (2013) Association of elevation, urbanization and ambient temperature with obesity prevalence in the United States. Int J Obes (Lond).
- 33. Voss J (2013) Obesity and Altitude. Obesity Panacea: PLoS Blogs. http://blogs.plos.org/obesitypanacea/2013/04/10/obesity-and-altitude/. Accessed: 8 Mar 2014.
- 34. Diabetes Data and Trends. Centers For Disease Control and Prevention. http://apps.nccd.cdc.gov/ddt_strs2/nationaldiabetesprevalenceestimates.aspx?mode=OBS. Accessed: 1 Sep 2013.
- 35. Sherpa LY, Deji, Stigum H, Chongsuvivatwong V, Thelle DS, et al. (2010) Obesity in Tibetans aged 30–70 living at different altitudes under the north and south faces of Mt. Everest. Int J Environ Res Public Health 7: 1670–1680. doi: 10.3390/ijerph7041670
- 36. Tyagi R, Tungdim MG, Bhardwaj S, Kapoor S (2008) Age, altitude and gender differences in body dimensions. Anthropol Anz 66: 419–434.
- 37. Meyer E, Carrillo R, Roman EM, Bejarano IF, Dipierri JE (2013) Prevalence of overweight and obesity in students from different altitudinal zones of Jujuy according to three international references (IOTF, CDC and WHO). Arch Argent Pediatr 111.
- 38. Shadish WR, Cook TD (2009) The renaissance of field experimentation in evaluating interventions. Annu Rev Psychol 60: 607–629. doi: 10.1146/annurev.psych.60.110707.163544
- 39. Hijmans RJ, Cameron SE, Parra JL, Jones PG, Jarvis A (2005) Very high resolution interpolated climate surfaces for global land areas. International journal of climatology 25: 1965–1978. doi: 10.1002/joc.1276
- 40. USA Zip Code Areas 3-digit. Geographic files derived from TomTom (2012) via ESRI http://www.arcgis.com/home/item.html?id=2690036a601b4e9a937466884a594938. Accessed: 13 Jan 2013.
- 41. Defense Travel Management Office. Browse Allowance Tables and Regulations Files (2009). http://www.defensetravel.dod.mil/site/pdcFiles.cfm?dir=/Allowances/BAH/Component_Breakdown/. Accessed: Nov 2013.
- 42. Le A, Judd SE, Allison DB, Oza-Frank R, Affuso O, et al. (2013) The Geographic Distribution of Obesity in the US and the Potential Regional Differences in Misreporting of Obesity. Obesity (Silver Spring).
- 43. stcox - Cox Proportional Hazards Model. http://www.stata.com/bookstore/stata12/pdf/st_stcox.pdf. (Stata Bookstore). Accessed: 1 Sep 2013.
- 44. Overweight and Obesity. Centers for Disease Control and Prevention (2011). http://www.cdc.gov/obesity/data/adult.html.Accessed: 20 Jun 2013.
- 45. List of ZIP code prefixes. Wikipedia. http://en.wikipedia.org/wiki/List_of_ZIP_code_prefixes. Accessed: 20 Jun 2013.
- 46. L002 3-Digit ZIP Code Prefix Matrix. United States Postal Service. http://pe.usps.gov/text/LabelingLists/L002.htm. Accessed: Mar 2014.
- 47. State Tobacco Activities Tracking and Evaluation System. Centers For Disease Control and Prevention. http://apps.nccd.cdc.gov/statesystem/TrendReport/TrendReports.aspx#ReportDetail. Accessed: Nov 2013.
- 48. Christakis NA, Fowler JH (2008) The collective dynamics of smoking in a large social network. N Engl J Med 358: 2249–2258. doi: 10.1056/nejmsa0706154
- 49. Clair C, Rigotti NA, Porneala B, Fox CS, D’Agostino RB, et al. (2013) Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 309: 1014–1021. doi: 10.1001/jama.2013.1644
- 50. Matthews LJ, DeWan P, Rula EY (2013) Methods for inferring health-related social networks among coworkers from online communication patterns. PLoS One 8: e55234. doi: 10.1371/journal.pone.0055234
- 51. Christakis NA, Fowler JH (2007) The spread of obesity in a large social network over 32 years. N Engl J Med 357: 370–379. doi: 10.1056/nejmsa066082
- 52. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, et al. (2002) Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 277: 42953–42957. doi: 10.1074/jbc.m206775200
- 53. Sierra-Johnson J, Romero-Corral A, Somers VK, Johnson BD (2008) Effect of altitude on leptin levels, does it go up or down? J Appl Physiol 105: 1684–1685. doi: 10.1152/japplphysiol.01284.2007
- 54. Baze MM, Schlauch K, Hayes JP (2010) Gene expression of the liver in response to chronic hypoxia. Physiol Genomics.
- 55. Young PM, Rose MS, Sutton JR, Green HJ, Cymerman A, et al. (1989) Operation Everest II: plasma lipid and hormonal responses during a simulated ascent of Mt. Everest. J Appl Physiol 66: 1430–1435.
- 56. Barnholt KE, Hoffman AR, Rock PB, Muza SR, Fulco CS, et al. (2006) Endocrine responses to acute and chronic high-altitude exposure (4,300 meters): modulating effects of caloric restriction. Am J Physiol Endocrinol Metab 290: E1078–1088. doi: 10.1152/ajpendo.00449.2005
- 57. Loshbaugh JE, Loeppky JA, Greene ER (2006) Effects of acute hypobaric hypoxia on resting and postprandial superior mesenteric artery blood flow. High Alt Med Biol 7: 47–53. doi: 10.1089/ham.2006.7.47
- 58. Teng R, Gavrilova O, Suzuki N, Chanturiya T, Schimel D, et al. (2011) Disrupted erythropoietin signalling promotes obesity and alters hypothalamus proopiomelanocortin production. Nat Commun 2: 520. doi: 10.1038/ncomms1526
- 59. Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, et al. (2008) The effect of altitude on dosing and response to erythropoietin in ESRD. J Am Soc Nephrol 19: 1389–1395. doi: 10.1681/asn.2007111181
- 60. Floyd ZE, Stephens JM (2012) Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPARgamma. Biochim Biophys Acta 1822: 1090–1095. doi: 10.1016/j.bbadis.2012.03.014
- 61. Budweiser S, Heinemann F, Meyer K, Wild PJ, Pfeifer M (2006) Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation. Respir Care 51: 126–132.
- 62. Obach R, Menargues A, Valles J, Valles JM, Garcia-Sevilla JA (1986) Effects of cyanamide on body weight and brain monoamines and metabolites in rats. Eur J Pharmacol 127: 225–231. doi: 10.1016/0014-2999(86)90368-7
- 63. Wilson MR, O’Dea KP, Dorr AD, Yamamoto H, Goddard ME, et al. (2010) Efficacy and safety of inhaled carbon monoxide during pulmonary inflammation in mice. PLoS One 5: e11565. doi: 10.1371/journal.pone.0011565
- 64. Ryter SW, Choi AM (2013) Carbon monoxide: present and future indications for a medical gas. Korean J Intern Med 28: 123–140. doi: 10.3904/kjim.2013.28.2.123
- 65. Scherer G, Conze C, von Meyerinck L, Sorsa M, Adlkofer F (1990) Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers. Int Arch Occup Environ Health 62: 459–466. doi: 10.1007/bf00379064
- 66. Csongradi E, Docarmo JM, Dubinion JH, Vera T, Stec DE (2012) Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice. Int J Obes (Lond) 36: 244–253. doi: 10.1038/ijo.2011.78
- 67. Hosick P, AlAmodi A, Storm M, Gousset M, Pruett B, et al. (2013) Chronic carbon monoxide treatment attenuates development of obesity and remodels adipocytes in mice fed a high-fat diet. International Journal of Obesity.
- 68. Reiter CE, Alayash AI (2012) Effects of carbon monoxide (CO) delivery by a CO donor or hemoglobin on vascular hypoxia inducible factor 1alpha and mitochondrial respiration. FEBS Open Bio 2: 113–118. doi: 10.1016/j.fob.2012.05.003
- 69. Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EH, Feskens EJ, et al. (2013) Iron metabolism is associated with adipocyte insulin resistance and plasma adiponectin: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Diabetes Care 36: 309–315. doi: 10.2337/dc12-0505
- 70. Gabrielsen JS, Gao Y, Simcox JA, Huang J, Thorup D, et al. (2012) Adipocyte iron regulates adiponectin and insulin sensitivity. J Clin Invest 122: 3529–3540. doi: 10.1172/jci44421
- 71. Minamiyama Y, Takemura S, Kodai S, Shinkawa H, Tsukioka T, et al. (2010) Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 298: E1140–1149. doi: 10.1152/ajpendo.00620.2009
- 72. Ri-Li G, Chase PJ, Witkowski S, Wyrick BL, Stone JA, et al. (2003) Obesity: associations with acute mountain sickness. Ann Intern Med 139: 253–257. doi: 10.7326/0003-4819-139-4-200308190-00007
- 73. Fiedler KK, Kim N, Kondo DG, Renshaw PF (2012) Cocaine use in the past year is associated with altitude of residence. J Addict Med 6: 166–171. doi: 10.1097/adm.0b013e31824b6c62
- 74. Hamad N, Travis SP (2006) Weight loss at high altitude: pathophysiology and practical implications. Eur J Gastroenterol Hepatol 18: 5–10. doi: 10.1097/00042737-200601000-00002
- 75. Vats P, Ray K, Majumadar D, Joseph DA, Bayen S, et al. (2013) Changes in Cardiovascular Functions, Lipid Profile, and Body Composition at High Altitude in Two Different Ethnic Groups. High altitude medicine & biology 14: 45–52. doi: 10.1089/ham.2012.1071
- 76. Kessler R, Glasgow RE (2011) A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am J Prev Med 40: 637–644. doi: 10.1016/j.amepre.2011.02.023